共 50 条
- [41] Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4<middle dot>5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialLANCET NEUROLOGY, 2024, 23 (08): : 775 - 786Parsons, Mark W.Yogendrakumar, VignanChurilov, LeonidGarcia-Esperon, CarlosCampbell, Bruce C., VRussell, Michelle L.Sharma, GaganChen, ChushuangLin, LongtingChew, Beng LimNg, Felix C.Deepak, AkshayChoi, Philip M. C.Kleinig, Timothy J.Cordato, Dennis J.Wu, Teddy Y.Fink, John N.Ma, HenryPhan, Thanh G.Markus, Hugh S.Molina, Carlos A.Tsai, Chon-HawLee, Jiunn-TayJeng, Jiann-ShingStrbian, DanielMeretoja, AtteArenillas, Juan F.Buck, Brian H.Devlin, Michael J.Brown, HelenButcher, Ken S.O'Brien, BillySabet, ArmanWijeratne, TissaBivard, AndrewGrimley, Rohan S.Agarwal, SmritiMunshi, Sunil K.Donnan, Geoffrey A.Davis, Stephen M.Miteff, FerdinandSpratt, Neil J.Levi, Christopher R.
- [42] Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trialLANCET ONCOLOGY, 2016, 17 (09): : 1230 - 1239Zielinski, ChristophLang, IstvanInbar, MosheKahan, ZsuzsannaGreil, RichardBeslija, SemirStemmer, Salomon M.Zvirbule, ZaneteSteger, Guenther G.Melichar, BohuslavPienkowski, TadeuszSirbu, DanielaPetruzelka, LubosEniu, AlexandruNisenbaum, BellaDank, MagdalenaAnghel, RodicaMessinger, DiethelmBrodowicz, Thomas
- [43] Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trialLANCET HIV, 2016, 3 (09): : E421 - E430Butler, KarinaTurkova, AnnaInshaw, JamieCompagnucci, AlexandraKenny, JuliaSaidi, YacineMusiime, VictorNanduudu, AnnettCressey, Tim R.Chalermpantmetagul, SuwalaiScott, KarenHarper, LyndaMontero, SamRiault, YoannBunupuradah, TorsakVolokha, AllaFlynn, Patricia M.Bologna, RosaKizito, HildaRamos, Jose T.Nastouli, EleniKlein, NigelGiaquinto, CarloFord, DeborahBabiker, AbdelGibb, Diana M.
- [44] The clinical effectiveness and cost-effectiveness of a ‘stepping into day treatment’ approach versus inpatient treatment as usual for anorexia nervosa in adult specialist eating disorder services (DAISIES trial): a study protocol of a randomised controlled multi-centre open-label parallel group non-inferiority trialTrials, 23Madeleine IrishBethan DaltonLaura PottsCatherine McCombieJames ShearerKatie AuNikola KernSam Clark-StoneFrances ConnanA. Louise JohnstonStanimira LazarovaShiona MacdonaldCiarán NewellTayeem PathanJackie WalesRebecca CashmoreSandra MarshallJon ArcelusPaul RobinsonHubertus HimmerichVanessa C. LawrenceJanet TreasureSarah ByfordSabine LandauUlrike Schmidt
- [45] The clinical effectiveness and cost-effectiveness of a 'stepping into day treatment' approach versus inpatient treatment as usual for anorexia nervosa in adult specialist eating disorder services (DAISIES trial): a study protocol of a randomised controlled multi-centre open-label parallel group non-inferiority trialTRIALS, 2022, 23 (01)Irish, MadeleineDalton, BethanPotts, LauraMcCombie, CatherineShearer, JamesAu, KatieKern, NikolaClark-Stone, SamConnan, FrancesJohnston, A. LouiseLazarova, StanimiraMacdonald, ShionaNewell, CiaranPathan, TayeemWales, JackieCashmore, RebeccaMarshall, SandraArcelus, JonRobinson, PaulHimmerich, HubertusLawrence, Vanessa C.Treasure, JanetByford, SarahLandau, SabineSchmidt, Ulrike
- [46] Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trialLANCET ONCOLOGY, 2023, 24 (03): : 213 - 227Brown, Janet E.Royle, Kara-LouiseGregory, WalterRalph, ChristyMaraveyas, AnthonyDin, OmarEisen, TimothyNathan, PaulPowles, TomGriffiths, RichardJones, RobertVasudev, NaveenWheater, MatthewHamid, AbdelWaddell, TomMcMenemin, RhonaPatel, PoulamLarkin, JamesFaust, GuyMartin, AdamSwain, JayneBestall, JanineMcCabe, ChristopherMeads, DavidGoh, VickyWah, Tze MinBrown, JuliaHewison, JennySelby, PeterCollinson, Fiona
- [47] Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trialLANCET NEUROLOGY, 2023, 22 (02): : 137 - 146Moniche, FranciscoCabezas-Rodriguez, Juan AntonioValverde, RobertoEscudero-Martinez, IreneLebrato-Hernandez, LuciaPardo-Galiana, BlancaAinz, LeireMedina-Rodriguez, Manuelde la Torre, JavierEscamilla-Gomez, VirginiaOrtega-Quintanilla, JoaquinZapata-Arriaza, Elenade Alboniga-Chindurza, AsierMancha, FernandoGamero, Miguel-AngelPerez, SoledadEspinosa-Rosso, RaulForero-Diaz, LuciaMoya, MiguelPinero, PilarCalderon-Cabrera, CristinaNogueras, SoniaJimenez, RosarioMartin, VanesaDelgado, FernandoOchoa-Sepulveda, Juan-JoseQuijano, BlancaMata, RosarioSantos-Gonzalez, MonicaCarmona-Sanchez, GloriaHerrera, ConchaGonzalez, AlejandroMontaner, Joan
- [48] Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17years in China: a randomised, double-blind, placebo- controlled, phase 1trial and an open-label, non-randomised, non-inferiority, phase 2 trialLANCET CHILD & ADOLESCENT HEALTH, 2023, 7 (04): : 269 - 279Gao, LidongLi, YanHe, PengChen, ZhenYang, HuaiyuLi, FangjunZhang, SiyuanWang, DanniWang, GuangyanYang, ShilongGong, LihuiDing, FanLing, MengyuWang, XiluCi, LeileiDai, LianpanGao, George FuHuang, TaoHu, ZhongyuYing, ZhifangSun, JiufengZuo, Xiaohu
- [49] Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trialLANCET ONCOLOGY, 2022, 23 (10): : 1308 - 1320Tree, Alison C.Ostler, Petervan der Voet, HansChu, WilliamLoblaw, AndrewFord, DanielTolan, ShaunJain, SuneilMartin, AlexanderStaffurth, JohnArmstrong, JohnCamilleri, PhilipKancherla, KiranFrew, JohnChan, AndrewDayes, Ian S.Duffton, AileenBrand, Douglas H.Henderson, DanielMorrison, KirstyBrown, StephaniePugh, JuliaBurnett, StephanieMahmud, MuneebHinder, VictoriaNaismith, OliviaHall, Emmavan As, Nicholas
- [50] Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trialLANCET, 2014, 384 (9951): : 1349 - 1357Dungan, Kathleen M.Tofe Povedano, SantiagoForst, ThomasGonzalez Gonzalez, Jose G.Atisso, CharlesSealls, WhitneyFahrbach, Jessie L.